高盛：上调 MSCI 新兴市场指数至1370 点

Group 1: Trade and Economic Outlook - The U.S. plans to increase tariffs on imports starting August 1, with a general tariff level similar to the previously announced "reciprocal" tariffs [1] - The assumption for baseline tariff levels remains at 10% for most countries and 25% for key goods, with potential adjustments if higher tariffs are implemented for an extended period [1] - Emerging market stocks have shown strong performance, prompting an upward revision of the MSCI Emerging Markets Index target from 1290 to 1370 points, with a projected 12-month return of 11% [1] Group 2: Company Performance - Laopuhuangjin - Laopuhuangjin expects a significant increase in sales and net profit for the first half of 2025, with projections of 268% and 284% growth, respectively [2] - Key assumptions include a 202% increase in average sales per store and the opening of three new stores, despite a slight decline in gross margin [2] Group 3: Automotive Industry Insights - The Chinese automotive industry anticipates continued government support and subsidies, with no sudden termination expected [4] - Intense competition is expected to persist in the industry over the next 2-3 years, despite government efforts to curb disorderly competition [4] - Automakers with overseas operations have reported strong sales, with local production capacity progressing as planned [4] Group 4: Automotive Technology Developments - There is increasing customer recognition of autonomous driving technology, with accelerated adoption of lidar and in-house developed advanced driver assistance system chips [5] Group 5: Company Performance - Dongpeng Beverage and Lanke Technology - Dongpeng Beverage's revenue is projected to grow by 35% in 2025, with net profit growth expected to be between 17%-29% [6] - Lanke Technology anticipates a 52% year-on-year revenue increase in 2025, driven by the ramp-up of DDR5 and third-generation interface chips [7] Group 6: Healthcare Sector Outlook - The CDMO sector is expected to see strong performance, with increased investor interest in CRO/CDMO and medical technology as the 2025 earnings season approaches [8] Group 7: Company Performance - Bilibili - Bilibili's investor day highlighted confidence in achieving above-industry advertising growth, with a focus on game product line improvements and enhanced advertising efficiency [9]